- High exposure to a specific industry (pharmaceuticals) and dependence on a few major products
- Acquired products may fail to obtain regulatory authorization
- Competitive market with risks from new innovative products and patent expirations
- Exposure to currency, interest rate, and liquidity risks
- Lack of data from third-party suppliers for accurate Scope 3 emissions tracking
Immedica Pharma Holding AB
Greenhouse gas emissions & sustainability report data
In its 2022 reporting, Immedica Pharma Holding AB disclosed greenhouse gas emissions of 3.6K tCO2e/year (Scope 1: 36.65 tCO2e Scope 2: 0.30 tCO2e Scope 3: 3601.25 tCO2e). By scope: Scope 1: 36.65 tCO2e/year; Scope 2: 0.30 tCO2e/year; Scope 3: 3.6K tCO2e/year. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.
GHG Emissions
3.6K tCO2e/year (Scope 1: 36.65 tCO2e Scope 2: 0.30 tCO2e Scope 3: 3601.25 tCO2e)
2022
Renewable Energy
100% at new HQ
of total energy
📊 Emissions by Scope (2022)
| Scope | What it covers | Reported value |
|---|---|---|
| Scope 1 | Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions). | 36.65 tCO2e/year |
| Scope 2 | Indirect emissions from purchased electricity, steam, heat and cooling. | 0.30 tCO2e/year |
| Scope 3 | Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.). | 3.6K tCO2e/year |
New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.
✅ Reported Environmental Achievements
- New HQ office in Stockholm sources 100% renewable energy
- Increased share of environmentally friendly cars in the fleet from 42% to 65%
🎯 Climate & Sustainability Targets
🔜 Short-term
- Set targets for scope 1 and 2 emissions
📅 Medium-term
- By January 2024, all new cars shall be 100% hybrid or electrical
🌱 ESG Focus Areas
Commitment to make a difference to patients’ livesSustainable organization and operations